Private Trust Company’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.6M Buy
9,688
+879
+10% +$898K 0.93% 12
2026
Q1
$8.1M Sell
8,809
-113
-1% -$115K 0.72% 17
2025
Q4
$9.59M Sell
8,922
-609
-6% -$582K 0.84% 14
2025
Q3
$7.27M Sell
9,531
-2,448
-20% -$1.82M 0.64% 22
2025
Q2
$9.34M Buy
11,979
+526
+5% +$409K 0.89% 13
2025
Q1
$9.46M Buy
11,453
+23
+0.2% +$19.1K 0.97% 10
2024
Q4
$8.82M Sell
11,430
-859
-7% -$711K 0.91% 12
2024
Q3
$10.9M Buy
12,289
+209
+2% +$188K 1.1% 8
2024
Q2
$10.9M Buy
12,080
+923
+8% +$738K 1.18% 8
2024
Q1
$8.68M Sell
11,157
-12
-0.1% -$8.54K 0.94% 10
2023
Q4
$6.51M Buy
11,169
+834
+8% +$487K 0.76% 17
2023
Q3
$5.55M Buy
10,335
+64
+0.6% +$33K 0.73% 24
2023
Q2
$4.82M Buy
10,271
+4
+0% +$1.68K 0.61% 29
2023
Q1
$3.53M Buy
10,267
+682
+7% +$230K 0.48% 36
2022
Q4
$3.51M Buy
9,585
+310
+3% +$110K 0.52% 29
2022
Q3
$3M Sell
9,275
-982
-10% -$311K 0.49% 37
2022
Q2
$3.33M Buy
10,257
+410
+4% +$123K 0.52% 35
2022
Q1
$2.82M Sell
9,847
-291
-3% -$74.9K 0.44% 59
2021
Q4
$2.8M Sell
10,138
-92
-0.9% -$23.3K 0.39% 74
2021
Q3
$2.36M Sell
10,230
-144
-1% -$35.5K 0.34% 84
2021
Q2
$2.38M Buy
10,374
+53
+0.5% +$10.6K 0.36% 79
2021
Q1
$1.93M Buy
10,321
+1,530
+17% +$299K 0.31% 90
2020
Q4
$1.48M Buy
8,791
+1,564
+22% +$234K 0.25% 106
2020
Q3
$1.07M Buy
7,227
+333
+5% +$51.5K 0.21% 121
2020
Q2
$1.15M Buy
6,894
+2,288
+50% +$351K 0.24% 109
2020
Q1
$638K Sell
4,606
-790
-15% -$109K 0.17% 140
2019
Q4
$709K Buy
5,396
+241
+5% +$27.9K 0.13% 175
2019
Q3
$576K Sell
5,155
-1,159
-18% -$129K 0.11% 212
2019
Q2
$699K Buy
6,314
+233
+4% +$27.4K 0.14% 167
2019
Q1
$789K Buy
6,081
+115
+2% +$14K 0.16% 148
2018
Q4
$690K Buy
5,966
+61
+1% +$6.81K 0.16% 150
2018
Q3
$633K Sell
5,905
-2,941
-33% -$294K 0.13% 197
2018
Q2
$754K Sell
8,846
-26
-0.3% -$2.14K 0.16% 152
2018
Q1
$686K Buy
8,872
+106
+1% +$8.53K 0.15% 173
2017
Q4
$740K Buy
8,766
+488
+6% +$41.5K 0.16% 168
2017
Q3
$708K Sell
8,278
-240
-3% -$19.7K 0.15% 162
2017
Q2
$700K Buy
8,518
+731
+9% +$59.6K 0.15% 159
2017
Q1
$654K Buy
7,787
+2,360
+43% +$189K 0.15% 164
2016
Q4
$399K Buy
5,427
+301
+6% +$22.4K 0.1% 240
2016
Q3
$411K Buy
5,126
+147
+3% +$11.8K 0.1% 226
2016
Q2
$392K Sell
4,979
-405
-8% -$30.5K 0.1% 226
2016
Q1
$387K Buy
5,384
+16
+0.3% +$1.21K 0.1% 222
2015
Q4
$452K Buy
5,368
+107
+2% +$8.88K 0.13% 192
2015
Q3
$440K Sell
5,261
-83
-2% -$7.01K 0.13% 191
2015
Q2
$446K Buy
5,344
+76
+1% +$5.79K 0.13% 206
2015
Q1
$382K Buy
5,268
+257
+5% +$18.3K 0.11% 221
2014
Q4
$345K Sell
5,011
-562
-10% -$37.9K 0.11% 217
2014
Q3
$361K Buy
5,573
+273
+5% +$17.3K 0.12% 193
2014
Q2
$329K Buy
5,300
+341
+7% +$20.3K 0.11% 213
2014
Q1
$292K Sell
4,959
-36,594
-88% -$2.04M 0.11% 203
2013
Q4
$2.12M Buy
41,553
+107
+0.3% +$5.36K 0.85% 23
2013
Q3
$2.09M Buy
41,446
+825
+2% +$43.2K 0.94% 18
2013
Q2
$2M Buy
+40,621
New +$2.21M 0.92% 22

Other funds holding LLY

Private Trust Company's LLY Position: Q2 2026 in Review

Private Trust Company increased its Eli Lilly (LLY) stake by 10% in Q2 2026, buying an estimated $898K and bringing the position to 9,688 shares worth $11.6M. The position accounts for 0.93% of the portfolio, ranked #12.

Private Trust Company first reported a position in LLY in Q2 2013 and has held it in 53 quarters since. 4,613 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Private Trust Company held 9,688 shares of Eli Lilly worth $11.6M as of Q2 2026.
  • Private Trust Company bought 879 Eli Lilly shares in Q2 2026, an estimated $898K.
  • Eli Lilly made up 0.93% of Private Trust Company's portfolio in Q2 2026, its #12 holding.
  • Private Trust Company first reported a position in Eli Lilly in Q2 2013 and has held it in 53 quarters since.
  • 4,613 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Private Trust Company's 13F filing for Q2 2026, filed 28 Jul 2026.